Background: Urothelial carcinoma (UC) is derived from the urothelium of the urinary tract, and includes cancers of the bladder, renal pelvis and ureter. The aim of this study was to investigate the clinical and demographic features among patients with bladder cancer and urothelial carcinoma of the upper urinary tract (UTUC) in Taiwan. Methods: The present study recruited a total of 736 histopathologically confirmed UC cases, which consisted of 470 bladder cancer and 266 UTUC between September 1998 and December 2009. Clinical and demographic features were collected by an interview utilizing a structured questionnaire, and supplemented by medical chart review. This study was approved by institutional review boards of the collaborating hospitals.
Introduction
Urothelial carcinoma (UC) can arise from the urothelium of the urinary tract, including the bladder, renal pelvis, and ureter. Bladder cancer is the second most common malignancy of the genitourinary tract and is the eighth most common cause of male malignancy in Taiwanese population. 1 Conversely, urothelial carcinoma of the upper urinary tract (UTUC) of the renal pelvis and ureter is a rare and heterogeneous disease that accounts for approximately 5% of all UC patients. 2 According to the Taiwan Cancer Registry Annual Report in 2013, the age-standardized incidence rate of UTUC per 100,000 population was 4.09 in men and 4.37 in women. Therefore, UTUC is a relatively uncommon cancer type in Taiwan. Research has shown that Taiwanese man were two times more likely to have UTUC than women in other Western countries, 3e5 while the male-to-female ratio is 1:1.2 in Taiwanese population. 6e9 Although UTUC of the renal pelvis and ureter is uncommon and comprises 23% of all UC patients in black-foot disease (BFD)-endemic areas with arsenic exposure in southwestern Taiwan, this phenomenon still represents a higher percentage than in other countries. 6, 10 Several risk factors such as arsenic exposure, cigarette smoking, and exposure to hazardous chemicals are associated with UC. 1, 8 The highest incidence of bladder cancer has been found in the BFD-endemic areas in Taiwan. 11, 12 Epidemiological studies have reported that chronic arsenic exposure through drinking well water is associated with bladder cancer. 13, 14 Previous studies reported that a higher incidence of UTUC is significantly associated with arsenic exposure, cigarette smoking and occupational carcinogens. 7, 8 Cigarette smoking is the major risk factor for UC, resulting in a 2e4-fold risk among ever smokers. 1, 15, 16 Chemical carcinogens exposure to occupations such as painting and working with dye are known risk factors of UC. 1, 17 Recently, our study showed that arsenic exposure, cigarette smoking, and risk genotypes of vascular endothelial growth factor contributed to a higher risk of UTUC than that of bladder cancer. 9 These findings suggest that clinical, epidemiological and molecular differences may be exist between bladder cancer and UTUC.
Despite the fact that UC is derived from the urothelium from the renal pelvis to the urethra, bladder cancer and UTUC have been proposed to represent different entities, based on their differing locations and embryonic derivation from different structures. 18 UTUC has been reported to be associated with a more aggressive disease course, and frequently went undiagnosed until the more-advanced stages relative to bladder cancer.
19e22 A better understanding of the differences between bladder cancer and UTUC might help to guide clinical decision-making. Therefore, the aim of this study was to identify the clinical and demographic characteristics for bladder cancer and UTUC in a Taiwanese population.
Methods

Study participants
This study consisted of 736 study participants and was conducted between September 1998 and December 2009. All histopathologically confirmed UC cases including 470 patients with bladder cancer and 266 patients with UTUC, who were recruited from the Department of Urology by way of collaborative hospitals. Pathological confirmation of UC was performed by customary urological practices that include endoscopic biopsy and surgical resection of urinary tract cancers. Based on the World Health Organization (WHO) grading system, the histopathological characteristics of UC was classified into 3 tumor grades (G1e3). Tumor staging of patients (stages T1e4) was classified using the 1997 American Joint Committee on Cancer (AJCC)-tumor node metastasis (TNM) system. In the present study, many UC patients were identified as T1 stage and not every tumor specimen was available by transurethral resection of bladder tumor (TURBT) for pathological local stage examination. Therefore, the lymph node status can not verifiably be determined by pathological examination. In addition to pathological local stage, clinical stage is evaluated by physical examination, cystoscopic tumor biopsy and any diagnostic imaging such as computed tomography (CT) scan. This testing provides available information including tumor size, infiltrative depth, and lymph nodes involvement, therefore, clinical stage is considered to be a complementary index for the assessment of relevant treatments of UC in clinical practice. All study participants received a detailed description of this study and provided written informed consent before inclusion.
Exposure information of risk factors
During the recruiting process, each study participant was interviewed in-person using a standard questionnaire to collect information including demographic characteristics, disease history, history of cigarette smoking and alcohol consumption, and exposure to hazardous chemicals such as the components of hair dye, leather, fabric, and paint. According to definitions provided by the U.S. Centers for Disease Control, individuals who had smoked in excess of 100 cigarettes during their lifetime were defined as "ever smokers" and the others were designated as "never smokers". 23 "Ever drinkers" were recognized as subjects who had consumed alcohol 3 or more days per week for a period of at least 6 months and the others were "never drinkers". In addition, study subjects who had been exposed to 2 or more hazardous chemicals including dye for hair, leather, fabric, or paint 7 or more times per week for a period of at least 1 month were classified as "ever exposed" and those study subjects without this exposure history were regarded as "never exposed".
Based on previous studies regarding chronic arsenic exposure in Taiwan, we further classified the residential areas into three zones. 1, 24, 25 The core zone (CZ) refers to four townships (Peimen, Hsuechia, Putai and Ichu) which are located in the BFD-endemic areas with well water arsenic concentration levels ranging from 350 mg/L to 1140 mg/L. The median arsenic concentrations of the artesian well water in this area ranged from 700 mg/L to 930 mg/L. The zone 1 (Z1) refers to the area surrounding the CZ area, where the well water arsenic concentration is equal to or greater than 350 mg/L, but is not a BFD-endemic area. Zone 2 (Z2) refers to other areas where the arsenic concentration in well water is lower than 350 mg/L. Individuals who lived in the CZ and Z1 areas who consumed well water for more than 10 years were regarded as highexposure group, whereas the others were regarded as lowexposure group.
Statistical analysis
Differences in patient demographic and clinical characteristics among bladder cancer, and UTUC were compared using the chi-square test for categorical variables and the Student's ttest for continuous variable. Continuous variables were expressed as the mean and standard deviation (SD). The Cox proportional hazards model was used to evaluate independent prognostic factors for disease-free survival (DFS), and overall survival (OS) of bladder cancer and UTUC were assessed by estimating the hazard ratio (HR) and its 95% confidence interval (CI). The P-values of <0.05 were considered statistically significant, and all analyses were performed using Statistical Analysis Software for Windows, version 9.1 (SAS Institute, Cary, NC, USA).
Results
No significant difference in the mean age was found between bladder cancer (66.8 ± 12.2 years) and UTUC (67.6 ± 11.6 years). The proportion of female patients in UTUC group (53.8%) was significantly higher than that in bladder cancer group (25.1%). Table 1 shows the comparison of demographic characteristics between bladder cancer and UTUC patients. The frequencies of cigarette smoking and alcohol consumption in the bladder cancer group (55.3% and 23.4%) were significantly higher than that in the UTUC group (33.5% and 14.7%). There were no significant differences in high-risk occupation and arsenic exposure between bladder cancer and UTUC patients. Comparison of clinicopathologic characteristics between bladder cancer and UTUC patients were shown in Table 2 . Compared with the bladder cancer group, UTUC also had a significantly higher frequency of advanced clinical stage (T2e4) (55.9% in UTUC vs. 31.6% in bladder cancer), as well as that of poor cell differentiation (G3) (52.8% in UTUC vs. 40.8% in bladder cancer). There were no significant differences in lymph nodes status and distant metastasis between bladder cancer and UTUC patients.
We estimated the correlation of demographic and clinicopathologic characteristics with disease-free survival (DFS) and overall survival (OS). The findings of univariate and multivariate analyses for DFS and OS were shown in Tables 3 and 4, respectively. In the univariate analysis, we found that male, ever smokers and high tumor grade were significant risk factors for DFS of UTUC (Table 3) . However, only the advanced clinical stage (T4) as well as high tumor grade have UTUC: Upper Urinary Tract (renal pelvis and ureter) Urothelial Carcinoma. a The differences between bladder cancer and UTUC were compared using a chi-square test.
b The mean ± SD of age in bladder cancer and UTUC cancers were compared using a student's t-test. increased risks (HR ¼ 2.4 and 3.0, respectively) for DFS of UTUC, with borderline significance in a multivariate analysis. In addition, high tumor grade was a significant risk factor for DFS of bladder cancer (HR ¼ 1.7) in the multivariate analysis.
In Table 4 , both cigarette smoking and alcohol consumption were not significantly associated with overall survival. The advanced clinical stage (T2e3 and T4) and high tumor grade were significant risk factors for the OS of bladder cancer patients in univariate and multivariate analyses, respectively. For UTUC patients, advanced clinical stage (T4) was a significant risk factor for OS in univariate (HR ¼ 9.6, P < 0.001) and multivariate (HR ¼ 8.7, P < 0.001) analyses. Regarding the effect of high tumor grade on the OS of UTUC, there were non-significant increased risks of 3.7 and 2.9 for univariate and multivariate analyses, respectively.
Discussion
Although UCs of the upper urinary tract and bladder are derived from the same urothelium, there were several clinical, molecular and demographic similarities and differences in the development and prognosis of UTUC and bladder cancer. Thus, in the present study we compared clinical and demographic features between the UTUC and bladder cancer in a Taiwanese population, as well as their relationship to potential prognostic factors of both disease-free survival and overall survival. Our results showed that men are nearly 3 times more likely to develop bladder cancer than women, which is similar to that reported from other countries. 26 However, the male-to-female ratio of UTUC was 1:1.16, showing a slight female predominance in the present study. Similarly, the male-to-female ratio of UTUC was 1:1.2 in previous studies conducted in Taiwan. 3e5 However, this ratio was different from the ratio of 2:1 in other Western countries. 3 To reduce the potential confounding effect, the gender adjustment was included in all analyses of this study. After adjusting for several well-known risk factors, gender did not appear to be significantly associated with survival outcomes in both bladder cancer and UTUC.
Chronic exposure to environmental risk factors have been reported to contribute to the development of UTUC. 8, 9 Some UTUC related risk factors were similar to those associated with bladder cancer. However, others were specific for UTUC only. Both cigarette smoking and risk of occupational exposure were the major risk factors for developing UCs. In particular, cigarette smoking represents a major risk factor for the development of UC. 1, 8 Burger et al. reported that smokers had higher cancer-specific mortality and bladder recurrence rates. 27 Our study found that cigarette smokers had nonsignificant higher risks of either bladder cancer or UTUC. However, cigarette smoking was not an independent prognostic factor for disease-free or overall survival of bladder cancer and UTUC, even after adjusting for tumor stage and grade. In addition, we found the proportion of alcohol consumption was significantly different between UTUC and bladder cancer patients. Zeegers et al. reported a higher UC risk of 1.3 for male alcohol drinkers. 28 However, any definite relationship between alcohol consumption and the development of UC was still not clear.
According to previous studies, a significant relationship between arsenic exposure through consumption of well water and bladder cancer risk has been reported. 13, 14 A high incidence of UTUC was not only observed in the BFD-endemic areas in southwestern Taiwan but also associated with arsenic exposure, cigarette smoking and carcinogens related to high-risk occupations. 7, 8 Although our results indicated that the proportion of high arsenic exposure was not significantly higher in UTUC patients than in bladder cancer patients, chronic arsenic exposure was still one of the major risk factors for both UTUC and bladder cancer.
The present study has shown that patients with UTUC had more advanced clinical stage (55.9% UTUC vs 31.6% bladder cancer with T2eT4) and poor differentiation (52.8% UTUC vs 40.8% bladder cancer with G3). Upon multivariate Cox regression analyses, we found that both advanced clinical stage (T2e4) and poor differentiation (G3) were stronger independent predictors of disease-free survival in UTUC patients than in bladder cancer patients. Similarly, we found that advanced clinical stage (T2e4) independently predicted worse overall survival in UTUC than bladder cancer. Although UTUC accounts for approximately 5% of all UCs, the aggressive potential of this tumor should be carefully followed. Clinico-pathological features such as tumor stage, grade, lymph nodes status, and distant metastasis were known prognostic factors of UTUC and bladder cancer. 21, 22 However, there were several controversies regarding the role of tumor sites, size, and adjuvant chemotherapy in the prognosis of UC. 29 These diverse results may be partially explained by various biologically significant common characteristics that exist between UTUC and bladder cancer. 30 In addition, chronic exposure to environmental risk factors may be more pronounced in the bladder due to its function of urine storage, perhaps suggesting different initiating risk factors in the development and prognosis of UTUC and bladder cancer. UTUC was considered as a part of a phenomenon that can yield multifocal tumors and transcend from the lower to the upper urinary tract. Furthermore, the average 5-year survival rate for patients with muscle-invasive UC was approximately 6e45%. Among those superficial cases, 10e30% progress to the advanced tumor stage, grade and poor prognosis. 21, 22 Therefore, both environmental risk factors exposure and clinicopathological features should be simultaneously included in multivariate models to identify potential prognostic factors, especially for survival analysis.
The present study had several limitations. First, no detailed information regarding the usage of Chinese herbs is unavailable in this study. Second, some study subjects lost detailed clinicopathological data such as tumor stage and grade. In addition, lymph node dissection will not be performed for early-stage UC in clinical practice. The pathological stage is not available, however, and clinical stage is recorded and used as a complementary index for the assessment of favorable treatments of UC in the present study. Third, the data of individual arsenic concentration in well water are not available in the present study. Based on the limited parameters and heterogeneous data, the present study merely observed that bladder cancer and UTUC patients with the higher clinical stage have a significant increased risk of poor overall survival. Moreover, the causal mechanisms of UC prognosis remained to be investigated in a larger population. Therefore, we have to interpret our results with a more conservative explanation. Recently, biomedical advances improved the capacity to discover novel molecular biomarkers for the clinical application in diagnosis, disease subtypes classification, disease prognosis and individual susceptibility to various treatments. Consequently, we should perform precision medicine research to integrate clinical features, environmental risk factors and potential molecular biomarkers for improving the clinical diagnosis, treatment and prognosis of UC.
